Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A Nephropathy

NCT00549692 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

152

Enrollment

INDUSTRY

Sponsor class

Conditions

IgA Nephropathy

Interventions

DRUG: Omega-3 fatty acid ethylester90

Sponsor

Kuhnil Pharmaceutical Co., Ltd.

Collaborators

[object Object]